Celyad Oncology SA (CLYYF)

USD 0.25

(0.0%)

Long Term Debt Summary of Celyad Oncology SA

  • Celyad Oncology SA's latest annual long term debt in 2023 was 902 Thousand EUR , up 664.41% from previous year.
  • Celyad Oncology SA's latest quarterly long term debt in 2024 Q2 was - EUR , down 0.0% from previous quarter.
  • Celyad Oncology SA reported annual long term debt of 118 Thousand EUR in 2022, down -93.18% from previous year.
  • Celyad Oncology SA reported annual long term debt of 1.73 Million EUR in 2021, down -31.49% from previous year.
  • Celyad Oncology SA reported quarterly long term debt of 902 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • Celyad Oncology SA reported quarterly long term debt of 351 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Celyad Oncology SA (2023 - 2011)

Historical Annual Long Term Debt of Celyad Oncology SA (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 902 Thousand EUR 664.41%
2022 118 Thousand EUR -93.18%
2021 1.73 Million EUR -31.49%
2020 2.52 Million EUR -15.95%
2019 3 Million EUR 240.98%
2018 881 Thousand EUR 9.03%
2017 808 Thousand EUR -11.89%
2016 917 Thousand EUR 114.75%
2015 427 Thousand EUR 53.05%
2014 279 Thousand EUR 928.76%
2013 27.12 Thousand EUR -97.06%
2012 921.38 Thousand EUR 692.54%
2011 116.25 Thousand EUR 0.0%

Peer Long Term Debt Comparison of Celyad Oncology SA

Name Long Term Debt Long Term Debt Difference
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 35.706%
CSL Limited 11.23 Billion USD 99.992%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -11175.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 48.618%
Propanc Biopharma, Inc. 58.64 Thousand USD -1438.147%
Mesoblast Limited 100.29 Million USD 99.101%
Marizyme, Inc. 667.12 Thousand USD -35.206%
Genus plc 228.2 Million USD 99.605%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 59.186%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 96.708%
AXIM Biotechnologies, Inc. 5.42 Million USD 83.378%
MultiCell Technologies, Inc. 36.43 USD -2475881.334%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 98.378%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 59.479%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 26.569%
Biomind Labs Inc. - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 52.488%
Skye Bioscience, Inc. 171.23 Thousand USD -426.777%
SQZ Biotechnologies Company 20.9 Million USD 95.686%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Intellipharmaceutics International Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.457%
Therapeutic Solutions International, Inc. 5512.00 USD -16264.296%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -180.124%
Alpha Cognition Inc. - USD -Infinity%
argenx SE 15.35 Million USD 94.125%
HST Global, Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -501.333%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -449.313%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 95.559%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -62.643%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -3465.358%
Endonovo Therapeutics, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
ONE Bio Corp. 592.19 Thousand USD -52.314%
Zenith Capital Corp. 4456.00 USD -20142.37%
Genscript Biotech Corporation 287.12 Million USD 99.686%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -614.161%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -293.387%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -292.701%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 89.085%
BioStem Technologies, Inc. 265.63 Thousand USD -239.564%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -84674.436%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -502.885%
Regen BioPharma, Inc. 149.61 Thousand USD -502.885%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -539.716%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -1027.5%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 88.465%
SYBLEU INC 300 Thousand USD -200.667%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -144.412%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD -102.697%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 88.933%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -97.374%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 22.308%
PureTech Health plc 18.25 Million USD 95.058%
Coeptis Therapeutics, Inc. 150 Thousand USD -501.333%
IXICO plc 275 Thousand USD -228.0%
IntelGenx Technologies Corp. 11.83 Million USD 92.381%
Gelesis Holdings, Inc. 26.3 Million USD 96.572%
CSL Limited 11.23 Billion USD 99.992%
Cellectis S.A. 36.21 Million USD 97.509%